Request for Public Comment on the Draft Immediately Dangerous to Life or Health (IDLH) Value Document for Hydrogen Chloride, 54319-54320 [2023-17129]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 153 / Thursday, August 10, 2023 / Notices
smartphones, or videophones are
available to incarcerated people who
need to use TRS for effective
communication, and all necessary TRS
provider software applications are
included, with any adjustments needed
to meet the security needs of the
institution. The Commission required
that providers ensure compatibility with
institutional communication systems
and allow operability over the inmate
calling services provider’s network.
On January 5, 2023, the President
signed into law the Martha Wright-Reed
Just and Reasonable Communications
Act of 2022, Public Law 117–338, 136
Stat. 6156 (the Martha Wright-Reed Act
or the Act), expanding the
Commission’s statutory authority over
communications services between
incarcerated people and the nonincarcerated to include ‘‘any audio or
video communications service used by
inmates . . . regardless of the
technology used.’’ The new Act also
amends section 2(b) of the
Communications Act of 1934, as
amended (the Communications Act) to
make clear that the Commission’s
authority extends to intrastate as well as
interstate and international
communications services used by
incarcerated people.
The Act directs the Commission to
‘‘promulgate any regulations necessary
to implement’’ the statutory provisions,
including its mandate that the
Commission establish a ‘‘compensation
plan’’ ensuring that all rates and charges
for IPCS ‘‘are just and reasonable,’’ not
earlier than 18 months and not later
than 24 months after its January 5, 2023
enactment. The Act also requires the
Commission to consider, as part of its
implementation, the costs of
‘‘necessary’’ safety and security
measures, as well as ‘‘differences in
costs’’ based on facility size, or ‘‘other
characteristics.’’ It also allows the
Commission to ‘‘use industry-wide
average costs of telephone service and
advanced communications services and
the average costs of service a
communications service provider’’ in
determining just and reasonable rates.
On March 17, 2023, pursuant to the
directive that the Commission
implement the new Act and establish
just and reasonable rates for IPCS
services, the Commission released
Incarcerated People’s Communications
Services; Implementation of the Martha
Wright-Reed Act; Rates for Interstate
Inmate Calling Services, WC Docket
Nos. 23–62, 12–375, Notice of Proposed
Rulemaking and Order, FCC 23–19, 88
FR 20804 (2023 IPCS Notice) and 88 FR
19001 (Order) (2023 IPCS Order). The
Commission sought comment on how to
VerDate Sep<11>2014
17:28 Aug 09, 2023
Jkt 259001
interpret the Act’s language to ensure
that the Commission implements the
statute in a manner that fulfills
Congress’s intent. Because the
Commission is now required or allowed
to consider certain types of costs, the
Act contemplates that it would
undertake an additional data collection.
To ensure that it has the data necessary
to meet its substantive and procedural
responsibilities under the Act, the
Commission adopted the 2023 IPCS
Order delegating authority to WCB and
the Office of Economics and Analytics
(OEA) to modify the template and
instructions for the most recent data
collection to the extent appropriate to
timely collect such information to cover
the additional services and providers
now subject to the Commission’s
authority. On April 28, 2023, WCB and
OEA issued a Public Notice seeking
comment on all aspects of the proposed
data collection. WCB and OEA Seek
Comment on Proposed 2023 Mandatory
Data Collection for Incarcerated
People’s Communication Services, WC
Docket Nos. 23–62, 12–375, Public
Notice, DA 23–355 (WCB/OEA Apr. 28,
2023). On July 26, 2023, WCB and OEA
released an Order adopting instructions,
a reporting template, and a certification
form to implement the 2023 Mandatory
Data Collection. Incarcerated People’s
Communications Services;
Implementation of the Martha WrightReed Act, Rates for Interstate Inmate
Calling Services, WC Docket Nos. 23–62,
12–375, Order, DA 23–638 (July 26,
2023).
In the 2023 IPCS Order, the
Commission also reaffirmed and
updated its prior delegation of authority
to WCB and the Consumer and
Governmental Affairs Bureau (CGB)
(collectively, the Bureaus) to revise the
instructions and reporting templates for
the Annual Reports. Specifically, the
Commission delegated to the Bureaus
the authority to modify, supplement,
and update the instructions and
templates for the Annual Reports, as
appropriate, to supplement the
information the Commission will
receive in response to the 2023
Mandatory Data Collection.
On August 3, 2023, the Bureaus
issued a Public Notice seeking comment
on proposed revisions to the
instructions, template, and certification
form for the Annual Reports, https://
www.fcc.gov/proposed-2023-ipcsannual-reports, which are necessary to
reflect the revised rules improving
access to communications services for
incarcerated people with
communication disabilities adopted in
the 2022 ICS Order and to help
implement the Martha Wright-Reed Act
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
54319
to ensure just and reasonable rates for
consumers and fair compensation for
providers. Wireline Competition Bureau
and Consumer and Governmental
Affairs Bureau Seek Comment on
Revisions to IPCS Providers’ Annual
Reporting and Certification
Requirements, Public Notice, WC
Docket Nos. 23–62, 12–375, DA 23–656
(Aug. 3, 2023). https://www.fcc.gov/
document/2023-incarcerated-peoplescommunications-services-annualreports-pn.
Notice of this document will be
published in the Federal Register. The
Bureaus will consider comments
submitted in response to the Public
Notice in addition to comments
submitted in response to this 60-Day
Notice in finalizing this information
collection prior to submitting the
documents to the Office of Management
and Budget.
Federal Communications Commission.
Katura Jackson,
Federal Register Liaison Officer.
[FR Doc. 2023–17257 Filed 8–9–23; 8:45 am]
BILLING CODE 6712–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number CDC–2023–0057, NIOSH–
156–F]
Request for Public Comment on the
Draft Immediately Dangerous to Life or
Health (IDLH) Value Document for
Hydrogen Chloride
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Request for comment.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH) in the Centers for Disease
Control and Prevention (CDC), an
Operating Division of the Department of
Health and Human Services (HHS),
requests public comment and technical
review on the draft Immediately
Dangerous to Life or Health (IDLH)
Value Profile document for the chemical
hydrogen chloride (CAS# 7647–01–0).
DATES: Electronic or written comments
must be received by October 10, 2023.
ADDRESSES: You may submit comments,
identified by docket number CDC–
2023–0057 and docket number NIOSH–
156–F, by either of the following
methods:
SUMMARY:
E:\FR\FM\10AUN1.SGM
10AUN1
ddrumheller on DSK120RN23PROD with NOTICES1
54320
Federal Register / Vol. 88, No. 153 / Thursday, August 10, 2023 / Notices
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, Ohio 45226–1998.
Instructions: All information received
in response to this notice must include
the agency name and docket number
(CDC–2023–0057; NIOSH–156–F). All
relevant comments, including any
personal information provided, will be
posted without change to https://
www.regulations.gov. Do not submit
comments by email. CDC does not
accept comments by email. For access to
the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: R.
Todd Niemeier, Ph.D., National Institute
for Occupational Safety and Health,
MS–C15, 1090 Tusculum Avenue,
Cincinnati, OH 45226. Telephone: (513)
533–8166.
SUPPLEMENTARY INFORMATION: NIOSH is
requesting public comment and
technical review on a draft IDLH Value
Profile document for the chemical
hydrogen chloride. To facilitate the
review of this document, NIOSH
requests comment on the following
specific questions for the draft Profile
document:
1. Does this document clearly outline
the health hazards associated with acute
(or short-term) exposures to the
chemical? If not, what specific
information is missing from the
document?
2. Are the rationale and logic behind
the derivation of an IDLH value for a
specific chemical clearly explained? If
not, what specific information is needed
to clarify the basis of the IDLH value?
3. Are the conclusions supported by
the data?
4. Are the tables clear and
appropriate?
5. Is the document organized
appropriately? If not, what
improvements are needed?
6. Are you aware of any scientific data
reported in government publications,
databases, peer-reviewed journals, or
other sources that should be included
within this document?
The draft IDLH Value Profile was
developed to provide the scientific
rationale behind derivation of IDLH
values for the following chemical:
Document #
Chemical
CAS #
X–XX .............
Hydrogen Chloride
(#7647–01–0)
The IDLH Value Profile provides a
detailed summary of the health hazards
VerDate Sep<11>2014
17:28 Aug 09, 2023
Jkt 259001
of acute exposures to high airborne
concentrations of the chemical and the
rationale for the IDLH value.
Background: In 2013, NIOSH
published Current Intelligence Bulletin
(CIB) 66: Derivation of Immediately
Dangerous to Life or Health (IDLH)
Values [https://www.cdc.gov/niosh/docs/
2014-100/pdfs/2014-100.pdf] [NIOSH
2013]. The information presented in this
CIB represents the scientific rationale
and the current methodology used to
derive IDLH values. Since the
establishment of the IDLH values in the
1970s, NIOSH has continued to review
available scientific data to improve the
protocol used to derive acute exposure
guidelines, in addition to the chemical
specific IDLH values.
IDLH values are based on health
effects considerations determined
through a critical assessment of the
toxicology and human health effects
data. This approach ensures that the
IDLH values reflect an airborne
concentration of a substance that
represents a high-risk situation that may
endanger workers’ lives or health.
The primary steps applied in the
establishment of an IDLH value include
the following:
1. Critical review of human and
animal toxicity data to identify
potentially relevant studies and
characterize the various lines of
evidence that can support the derivation
of the IDLH value;
2. Determination of a chemical’s mode
of action or description of how a
chemical exerts its toxic effects;
3. Application of duration
adjustments (time scaling) to determine
30-minute-equivalent exposure
concentrations and the conduct of other
dosimetry adjustments, as needed;
4. Experimental or other data to
establish a point of departure (POD)
such as lethal concentrations (e.g.,
LC50), lowest observed adverse effect
level (LOAEL), or no observed adverse
effect level (NOAEL);
5. Selection and application of an
uncertainty factor (UF) for POD or
critical adverse effect concentration,
identified from the available studies to
account for issues associated with
interspecies and intraspecies
differences, severity of the observed
effects, data quality, or data
insufficiencies; and
6. Development of the final
recommendation for the IDLH value
from the various alternative lines of
evidence, with use of a weight-ofevidence approach to all the data.
dangerous to life or health (IDLH) values.
Cincinnati, OH: US Department of Health
and Human Services, Centers for Disease
Control and Prevention, National Institute for
Occupational Safety and Health, DHHS
(NIOSH) Publication 2014–100.
Reference
Electronic Submissions
NIOSH [2013]. Current intelligence
bulletin 66: derivation of immediately
Submit electronic comments in the
following way:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Dated: August 4, 2023.
John J. Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2023–17129 Filed 8–9–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2023–N–3103]
Development of Small Dispensers
Assessment Under the Drug Supply
Chain Security Act; Request for
Comments
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; request for comments.
The Food and Drug
Administration (FDA or Agency) is
seeking stakeholder comments on the
development of a technology and
software assessment that examines the
feasibility of dispensers with 25 or
fewer full-time employees conducting
interoperable, electronic tracing of
products at the package level. FDA
would like to obtain information
regarding issues to be addressed in the
assessment related to the accessibility of
the necessary software and hardware to
such dispensers; whether the necessary
software and hardware is prohibitively
expensive to obtain, install, and
maintain for such dispensers; and if the
necessary hardware and software can be
integrated into business practices.
DATES: Either electronic or written
comments on the notice must be
submitted by September 11, 2023.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. The https://
www.regulations.gov electronic filing
system will accept comments until
11:59 p.m. Eastern Time at the end of
September 11, 2023. Comments received
by mail/hand delivery/courier (for
written/paper submissions) will be
considered timely if they are received
on or before that date.
SUMMARY:
E:\FR\FM\10AUN1.SGM
10AUN1
]]>Agencies
[Federal Register Volume 88, Number 153 (Thursday, August 10, 2023)]
[Notices]
[Pages 54319-54320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17129]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number CDC-2023-0057, NIOSH-156-F]
Request for Public Comment on the Draft Immediately Dangerous to
Life or Health (IDLH) Value Document for Hydrogen Chloride
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Request for comment.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) in the Centers for Disease Control and Prevention (CDC), an
Operating Division of the Department of Health and Human Services
(HHS), requests public comment and technical review on the draft
Immediately Dangerous to Life or Health (IDLH) Value Profile document
for the chemical hydrogen chloride (CAS# 7647-01-0).
DATES: Electronic or written comments must be received by October 10,
2023.
ADDRESSES: You may submit comments, identified by docket number CDC-
2023-0057 and docket number NIOSH-156-F, by either of the following
methods:
[[Page 54320]]
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: National Institute for Occupational Safety and
Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati,
Ohio 45226-1998.
Instructions: All information received in response to this notice
must include the agency name and docket number (CDC-2023-0057; NIOSH-
156-F). All relevant comments, including any personal information
provided, will be posted without change to https://www.regulations.gov.
Do not submit comments by email. CDC does not accept comments by email.
For access to the docket to read background documents or comments
received, go to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: R. Todd Niemeier, Ph.D., National
Institute for Occupational Safety and Health, MS-C15, 1090 Tusculum
Avenue, Cincinnati, OH 45226. Telephone: (513) 533-8166.
SUPPLEMENTARY INFORMATION: NIOSH is requesting public comment and
technical review on a draft IDLH Value Profile document for the
chemical hydrogen chloride. To facilitate the review of this document,
NIOSH requests comment on the following specific questions for the
draft Profile document:
1. Does this document clearly outline the health hazards associated
with acute (or short-term) exposures to the chemical? If not, what
specific information is missing from the document?
2. Are the rationale and logic behind the derivation of an IDLH
value for a specific chemical clearly explained? If not, what specific
information is needed to clarify the basis of the IDLH value?
3. Are the conclusions supported by the data?
4. Are the tables clear and appropriate?
5. Is the document organized appropriately? If not, what
improvements are needed?
6. Are you aware of any scientific data reported in government
publications, databases, peer-reviewed journals, or other sources that
should be included within this document?
The draft IDLH Value Profile was developed to provide the
scientific rationale behind derivation of IDLH values for the following
chemical:
------------------------------------------------------------------------
Document # Chemical CAS #
------------------------------------------------------------------------
X-XX............................. Hydrogen Chloride... (#7647-01-0)
------------------------------------------------------------------------
The IDLH Value Profile provides a detailed summary of the health
hazards of acute exposures to high airborne concentrations of the
chemical and the rationale for the IDLH value.
Background: In 2013, NIOSH published Current Intelligence Bulletin
(CIB) 66: Derivation of Immediately Dangerous to Life or Health (IDLH)
Values [https://www.cdc.gov/niosh/docs/2014-100/pdfs/2014-100.pdf]
[NIOSH 2013]. The information presented in this CIB represents the
scientific rationale and the current methodology used to derive IDLH
values. Since the establishment of the IDLH values in the 1970s, NIOSH
has continued to review available scientific data to improve the
protocol used to derive acute exposure guidelines, in addition to the
chemical specific IDLH values.
IDLH values are based on health effects considerations determined
through a critical assessment of the toxicology and human health
effects data. This approach ensures that the IDLH values reflect an
airborne concentration of a substance that represents a high-risk
situation that may endanger workers' lives or health.
The primary steps applied in the establishment of an IDLH value
include the following:
1. Critical review of human and animal toxicity data to identify
potentially relevant studies and characterize the various lines of
evidence that can support the derivation of the IDLH value;
2. Determination of a chemical's mode of action or description of
how a chemical exerts its toxic effects;
3. Application of duration adjustments (time scaling) to determine
30-minute-equivalent exposure concentrations and the conduct of other
dosimetry adjustments, as needed;
4. Experimental or other data to establish a point of departure
(POD) such as lethal concentrations (e.g., LC50), lowest observed
adverse effect level (LOAEL), or no observed adverse effect level
(NOAEL);
5. Selection and application of an uncertainty factor (UF) for POD
or critical adverse effect concentration, identified from the available
studies to account for issues associated with interspecies and
intraspecies differences, severity of the observed effects, data
quality, or data insufficiencies; and
6. Development of the final recommendation for the IDLH value from
the various alternative lines of evidence, with use of a weight-of-
evidence approach to all the data.
Reference
NIOSH [2013]. Current intelligence bulletin 66: derivation of
immediately dangerous to life or health (IDLH) values. Cincinnati,
OH: US Department of Health and Human Services, Centers for Disease
Control and Prevention, National Institute for Occupational Safety
and Health, DHHS (NIOSH) Publication 2014-100.
Dated: August 4, 2023.
John J. Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2023-17129 Filed 8-9-23; 8:45 am]
BILLING CODE 4163-18-P
